44 WEALTH MANAGEMENT LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1831187 EUGENE, OR

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$234,992

-$40,681 QoQ

Shares Held

1,860

-6.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#1,821

of 2,266 holders

Holding Since

Jun 2021

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

44 WEALTH MANAGEMENT LLC holds $16,913,142 across 10 Drug Manufacturers - General names. GILD ranks #10 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	23,812	$6,047,533
2	BMY	Bristol Myers Squibb Co	65,070	$3,749,333
3	MRK	Merck & Co., Inc.	15,847	$2,036,339
4	SNY	Sanofi	43,343	$1,849,012
5	LLY	ELI LILLY & Co	858	$1,029,111
6	AZN	Astrazeneca PLC	2,817	$534,159
7	NVS	Novartis AG	3,161	$495,391
8	AMGN	Amgen Inc	1,359	$492,121

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$234,992	1,860	-6.0%	Shares	Sole	2026-08-14
2026-03-31	$275,673	1,978	-32.6%	Shares	Sole	2026-05-15
2025-12-31	$360,119	2,934	+0.4%	Shares	Sole	2026-02-09
2025-09-30	$324,342	2,922	-0.0%	Shares	Sole	2025-11-14
2025-06-30	$324,073	2,923	+3.7%	Shares	Sole	2025-08-15
2025-03-31	$315,756	2,818	-4.3%	Shares	Sole	2025-04-29
2024-12-31	$272,029	2,945	-6.8%	Shares	Sole	2025-02-03
2024-09-30	$265,018	3,161	-6.9%	Shares	Sole	2024-10-25
2023-06-30	$261,652	3,395	-1.3%	Shares	Sole	2023-07-18
2023-03-31	$285,333	3,439	-2.2%	Shares	Sole	2023-04-20
2022-12-31	$302,020	3,518	-0.2%	Shares	Sole	2023-01-20
2022-09-30	$217,395	3,524	-13.0%	Shares	Sole	2022-10-12
2022-06-30	$250,392	4,051	-16.7%	Shares	Sole	2022-07-22
2022-03-31	$289,045	4,862	+20.9%	Shares	Sole	2022-04-18
2021-12-31	$292,110	4,023	+27.7%	Shares	Sole	2022-01-13
2021-09-30	$220,027	3,150	-4.9%	Shares	Sole	2021-10-20
2021-06-30	$228,133	3,313	—	Shares	Sole	2021-07-19
No filing history on record for this holder in this stock.